Artikel von Andreas Zehetner
Andreas Zehetner has been intensively engaged in various trading strategies since 2015 and is himself a passionate trend-following trader. In webinars and short video coaching sessions, he regularly presents different analysis methods. Focusing on the US market, Andreas identifies interesting breakout opportunities in leading growth stocks as part of the NEO-DARVAS strategy and based on the frameworks of legends like William O’Neil or Mark Minervini.Latest from Andreas Zehetner
AMD at an All-Time High - Advancing AI 2026 Event Could Support Trend Continuation!
EZCORP: Pawn Shop Operator Benefits from Record Loan Demand!
EZCORP as a financial partner for quick financial assistance without bureaucratic credit checks, as...
Uber Shapes a new Industry Giant - Delivery Hero Takeover bid for $14.8 Billion
Uber offers €41.50 per share for Delivery Hero, representing an equity value of $14.8 billion to...
General Dynamics Signs a $2.5 Billion Agreement - USA Aims to Accelerate Submarine Production
General Dynamics secures a strategic agreement worth $2.5 billion as part of an investment package...
NVIDIA Starts Deliveries of H200 Chips to China
NVIDIA has reportedly begun shipping its H200 chips to Chinese companies such as ZTE, Alibaba, and...
Abivax S.A.: All-Time High After Successful Capital Increase and Solid Study Data
Business model: Abivax S.A. is a clinical biotechnology company developing therapeutics to regulate...
MasTec - Specialist in Energy and Communication Networks with Record Order Backlog!
MasTec benefits in infrastructure construction from the secular trends surrounding data centers, renewable...
PayPal: Stripe and Advent International are Planning an Acquisition, According to Insiders
According to Reuters, payment processor Stripe and private equity investor Advent International are...
Tower Semiconductor Invests $3 Billion in Japan and Raises Price Targets for 2028
Tower Semiconductor expands its production capacity in Japan for $3 billion, for which the company...
Dutch Bros: My Favorite Among the Restaurant Stocks Starts the Trend Turnaround
Dutch Bros (BROS) is my favorite among restaurant stocks. I appreciate the clearly recognizable competitive...
SK Hynix: Change in Legislation in South Korea Could Facilitate Financing of new Chip Factories
A planned change in legislation in South Korea is set to allow SK Hynix to establish joint ventures...
NWPX Infrastructure: Investments in Water Infrastructure Drive the Stock to a new all-Time High
NWPX Infrastructure manufactures and distributes pipe systems made of steel and concrete for water...
Pursuit Attractions and Hospitality: Competitive Advantage with "Once in a Lifetime" Nature Experiences
Pursuit Attractions and Hospitality has a strong competitive advantage with unique and nature-based...
TSMC Reports Record Revenue for Q2 – June Revenue Increases by 68%
TSMC achieved a record revenue growth of 36% to over 39.6 in the second quarter. Revenues rose sharply...
nLight: Here's why the Pure Play for Laser Weapons is now Targeting its all-Time High
nLight (LASR) is a "pure play" in the high-performance laser sector for directed energy weapons and...
Aehr Test Systems Benefits From Follow-up Orders for AI and Silicon Photonics
Aehr Test Systems develops and produces test and burn-in systems for the semiconductor industry, used...
BridgeBio Pharma: Attruby Becomes a Blockbuster – Main Competitor Fails in Phase 3 Trial
Attruby experienced almost 400% growth in the US as a treatment for the rare heart disease ATTR-CM....
Exelixis: Zanzalintinib as a Major Hope in Cancer Therapies Ahead of FDA Approval
Business Model: Exelixis focuses on targeted cancer therapies with kinase inhibitors. The main product,...
Exelixis: Zanzalintinib as a Great Hope in Cancer Therapies Before FDA Approval
Business model: Exelixis focuses on targeted cancer therapies with kinase inhibitors. The main product...
Septerna: Specialist in Oral GPCR Drugs Impresses with Strong Pipeline
SEP-479 targets the potential billion-dollar market for hypoparathyroidism and aims to replace current...
FedEx focuses on the High-Margin Logistics Business with new Life Sciences Organization
The new organization "FedEx Life Sciences” focuses on highly complex logistics for pharmaceuticals,...